Kadmon Holdings Inc. | Mutual Funds
Mutual Funds that own Kadmon Holdings Inc.
Vanguard Total Stock Market Index Fund
2,630,102
2.33%
340,123
0%
07/31/2018
Vanguard Extended Market Index Fund
1,454,057
1.29%
0
0.01%
07/31/2018
iShares Russell 2000 ETF
1,453,776
1.29%
-777
0.01%
09/06/2018
Invesco Global Health Care Fund
959,467
0.85%
959,467
0.3%
06/29/2018
iShares Russell 2000 Growth ETF
685,910
0.61%
0
0.03%
09/06/2018
Fidelity Spartan Extended Market Index Fund
489,302
0.43%
0
0.01%
07/31/2018
Bridgeway Ultra Small Company Market Fund
283,000
0.25%
50,000
0.28%
12/31/2017
Fidelity Spartan Total Market Index Fund
207,825
0.18%
0
0%
07/31/2018
iShares Micro Cap ETF
186,094
0.17%
0
0.07%
09/06/2018
Invesco V.I. Global Health Care Fund
144,059
0.13%
144,059
0.3%
06/29/2018
| Address |
450 East 29th Street
New York New York 10016
United States
|
|
Employees
|
- |
| Website |
http://www.kadmon.com |
| Updated |
07/08/2019 |
| Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. |
